1. Home
  2. INHD vs XBIO Comparison

INHD vs XBIO Comparison

Compare INHD & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inno Holdings Inc.

INHD

Inno Holdings Inc.

HOLD

Current Price

$0.18

Market Cap

9.6M

Sector

N/A

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$3.48

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INHD
XBIO
Founded
2019
N/A
Country
Hong Kong
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
8.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
INHD
XBIO
Price
$0.18
$3.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.6M
15.0K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
17.61
N/A
EPS
N/A
N/A
Revenue
$2,846,250.00
N/A
Revenue This Year
N/A
$2.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
221.43
N/A
52 Week Low
$0.06
$1.90
52 Week High
$15.90
$13.93

Technical Indicators

Market Signals
Indicator
INHD
XBIO
Relative Strength Index (RSI) 19.21 54.38
Support Level $0.09 $2.70
Resistance Level $1.25 $3.60
Average True Range (ATR) 0.16 0.21
MACD -0.02 0.01
Stochastic Oscillator 0.95 51.03

Price Performance

Historical Comparison
INHD
XBIO

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: